ABBV
Abbvie Inc.
A global biopharmaceutical company, AbbVie develops and sells medicines for immune, nerve, and cancer conditions — brands include Skyrizi, Rinvoq, Humira, Botox, and Imbruvica — as well as cosmetic treatments like Botox Cosmetic and the Juvederm line. It was born in 2013 when Abbott Laboratories split, spinning off its drug business into a fresh company. Fun fact: the name blends "Abb" (from Abbott) with "Vie," echoing the Latin word for "life," and insiders noted it conveniently rhymes with "R&D."
CUSIP: 00287Y109HealthcareUS9 holders
Total Value
$70.29M
Total Shares
289.4K
Net Share Change
-25.3K
Activity
1 buying6 selling
Investor
Value
Shares
Weight
Change
